ACIU AC Immune SA Stock Quote

ACIU [NASD]

Healthcare | Biotechnology | Switzerland

Index	-	P/E	-	EPS (ttm)	-0.95	Insider Own	46.99%	Shs Outstand	71.93M	Perf Week	2.93%
Market Cap	559.65M	Forward P/E	-	EPS next Y	-0.56	Insider Trans	0.00%	Shs Float	34.30M	Perf Month	29.26%
Income	-68.40M	PEG	-	EPS next Q	-0.27	Inst Own	28.60%	Short Float	3.39%	Perf Quarter	38.78%
Sales	17.60M	P/S	31.80	EPS this Y	177.60%	Inst Trans	-2.77%	Short Ratio	1.14	Perf Half Y	3.62%
Book/sh	3.59	P/B	2.15	EPS next Y	38.50%	ROA	-22.10%	Target Price	13.25	Perf Year	10.74%
Cash/sh	3.77	P/C	2.05	EPS next 5Y	-	ROE	-24.20%	52W Range	4.07 - 13.00	Perf YTD	49.52%
Dividend	-	P/FCF	-	EPS past 5Y	26.30%	ROI	16.20%	52W High	-42.54%	Beta	0.82
Dividend %	-	Quick Ratio	18.10	Sales past 5Y	29.70%	Gross Margin	-	52W Low	83.54%	ATR	0.82
Employees	115	Current Ratio	18.10	Sales Q/Q	-96.70%	Oper. Margin	-	RSI (14)	51.57	Volatility	6.65% 12.66%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-204.80%	Profit Margin	-	Rel Volume	0.33	Prev Close	7.73
Shortable	Yes	LT Debt/Eq	0.01	Earnings	-	Payout	-	Avg Volume	1.02M	Price	7.47
Recom	1.70	SMA20	-2.70%	SMA50	14.04%	SMA200	16.16%	Volume	160,550	Change	-3.36%

Feb-01-19

Downgrade

UBS

Buy → Neutral

Jan-04-19

Initiated

UBS

Buy

Apr-05-18

Initiated

H.C. Wainwright

Buy

$18

Mar-23-18

Downgrade

Credit Suisse

Outperform → Neutral

Oct-18-16

Initiated

Leerink Partners

Outperform

Oct-18-16

Initiated

Jefferies

Buy

$25

Oct-18-16

Initiated

Credit Suisse

Outperform

$18

Feb-24-21 07:00AM	AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD 2021 Virtual Conference GlobeNewswire +6.66%
Feb-17-21 07:00AM	AC Immune to Highlight Promising Alzheimers Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference GlobeNewswire +13.13%
Feb-11-21 08:24PM	Why AC Immune Stock Surged Today Motley Fool +15.32%
04:23PM	This Dollar-Stock Biotech Popped In Bullish Volume On Its Alzheimer's News Investor's Business Daily
08:16AM	AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally Benzinga
07:00AM	AC Immunes Alzheimers Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study GlobeNewswire
Feb-08-21 07:00AM	AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinsons Disease GlobeNewswire +8.51%
Jan-29-21 07:00AM	AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway GlobeNewswire
Jan-24-21 01:01AM	New Forecasts: Here's What Analysts Think The Future Holds For AC Immune SA (NASDAQ:ACIU) Simply Wall St.
Jan-17-21 11:13PM	What Kind Of Shareholders Own AC Immune SA (NASDAQ:ACIU)? Simply Wall St.
Dec-15-20 08:00AM	AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay GlobeNewswire +5.62%
Dec-11-20 12:54PM	Is ACIU A Good Stock To Buy Now? Insider Monkey
Nov-20-20 08:40AM	Immunotherapy Pioneer Prof. Carl H. June Joins AC Immunes Board of Directors GlobeNewswire
Nov-18-20 07:00AM	Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer GlobeNewswire
Nov-13-20 10:10AM	AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:27AM	AC Immune: Q3 Earnings Insights Benzinga
07:00AM	AC Immune Reports Q3 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-12-20 07:00AM	AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-09-20 04:00AM	AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immunes Anti-TDP-43 Antibodies into Clinical Development GlobeNewswire +5.17%
Nov-04-20 12:30PM	Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline Zacks +16.81%
Oct-09-20 08:25AM	Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent GlobeNewswire
Oct-05-20 06:39AM	Companies Like AC Immune (NASDAQ:ACIU) Are In A Position To Invest In Growth Simply Wall St.
Sep-24-20 10:35AM	AC Immune's Candidate Fails in Alzheimer's Disease Study Zacks
Sep-23-20 10:19AM	Why AC Immune Stock Is Crashing Today Motley Fool -44.95%
07:00AM	AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimers Disease GlobeNewswire
Sep-11-20 07:00AM	AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire
Sep-01-20 08:54AM	Do Options Traders Know Something About AC Immune (ACIU) Stock We Don't? Zacks
Aug-21-20 08:05AM	Did AC Immune's (NASDAQ:ACIU) Share Price Deserve to Gain 34%? Simply Wall St. +8.01%
Aug-07-20 10:53AM	Aerie (AERI) Q2 Earnings Miss Estimates, Revenues Rise Y/Y Zacks
Aug-06-20 12:00PM	All You Need to Know About AC Immune (ACIU) Rating Upgrade to Strong Buy Zacks
Aug-05-20 11:25AM	AC Immune (ACIU) Reports Q2 Loss, Tops Revenue Estimates Zacks -6.81%
07:00AM	AC Immune Reports Q2 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-03-20 07:00AM	AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration GlobeNewswire +7.50%
Jul-30-20 07:55AM	AC Immune Wins Prestigious Award to Develop a Game-Changing Parkinsons Diagnostic Tool GlobeNewswire +5.81%
Jul-28-20 07:00AM	AC Immune Demonstrates Enhanced Performance of First-in-class Parkinsons Diagnostic Agent GlobeNewswire
Jul-23-20 07:00AM	AC Immune to Present Advances in Two of the Companys World Leading Programs at the Upcoming Alzheimers Association International Conference GlobeNewswire
Jul-17-20 10:04AM	AC Immune Advances Alzheimer's Vaccine to Phase Ib/IIa Study Zacks
07:41AM	The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient Benzinga
Jul-16-20 04:25PM	AC Immune Stock Catapults To Two-Year High On Alzheimer's News Investor's Business Daily +18.92%
03:01PM	Here's Why AC Immune Jumped Higher Today Motley Fool
08:29AM	AC Immune Explodes 56% In Pre-Market On Alzheimer Study Initiation SmarterAnalyst
07:00AM	AC Immune Advances phospho-Tau Alzheimers Vaccine in Phase 1b/2a Study GlobeNewswire
Jul-07-20 09:00AM	Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy GlobeNewswire +5.97%
06:51AM	How Much Of AC Immune SA (NASDAQ:ACIU) Do Insiders Own? Simply Wall St.
Jul-04-20 02:59PM	Hedge Funds Have Never Been This Bullish On AC Immune SA (ACIU) Insider Monkey
Jun-26-20 07:21AM	AC Immune Announces Results of Annual General Meeting GlobeNewswire
May-15-20 07:00AM	AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference GlobeNewswire
May-06-20 10:12AM	AC Immune SA (NASDAQ:ACIU) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates Simply Wall St.
May-04-20 08:35AM	AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates Zacks +9.68%
07:00AM	AC Immune Reports Q1 2020 Financial Results and Provides Business Update GlobeNewswire
Apr-28-20 11:16AM	Axsome Shares Jump 25% on Alzheimer's Study Results GuruFocus.com -6.98%
Apr-04-20 08:04AM	Newsflash: AC Immune SA (NASDAQ:ACIU) Analysts Have Been Trimming Their Revenue Forecasts Simply Wall St.
Apr-02-20 07:00AM	AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases GlobeNewswire +6.01%
Mar-30-20 07:00AM	AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook GlobeNewswire +14.96%
Mar-24-20 10:31AM	Company News for Mar 24, 2020 Zacks +7.81%
Mar-23-20 07:00AM	AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership GlobeNewswire +13.50%
Mar-20-20 07:19AM	Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immunes Clinical Advisory Board GlobeNewswire
Mar-18-20 09:43AM	Moderna (MRNA) Catches Eye: Stock Jumps 6.4% Zacks -10.55%
Mar-13-20 09:22AM	Guardant Health (GH) in Focus: Stock Moves 6.5% Higher Zacks -5.27%
Mar-05-20 07:00AM	AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimers and Parkinsons Therapies Focus Meeting GlobeNewswire
Feb-24-20 07:23AM	Is AC Immune SA's (NASDAQ:ACIU) CEO Pay Justified? Simply Wall St. -6.42%
Jan-30-20 10:37AM	Top Ranked Momentum Stocks to Buy for January 30th Zacks
Dec-24-19 04:57AM	AC Immune SA (NASDAQ:ACIU) Has A ROE Of 17% Simply Wall St.
Dec-16-19 01:46PM	Did Hedge Funds Drop The Ball On AC Immune SA (ACIU) ? Insider Monkey
Nov-14-19 07:00AM	AC Immune to Present at Jefferies 2019 London Healthcare Conference GlobeNewswire +5.21%
Nov-13-19 07:00AM	AC Immune Q3 2019 Financial Results and Business Update GlobeNewswire +16.61%
Nov-11-19 07:50AM	5 Biotech Stocks Set to Beat Q3 Earnings Estimates Zacks
Nov-08-19 10:25AM	Linde (LIN) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-06-19 04:05PM	AC Immune Hosts Key Opinion Leader Event: Untangling Tau Pathology to Treat Alzheimers and Neurodegenerative Diseases GlobeNewswire
02:31PM	Were Hedge Funds Right About Souring On AC Immune SA (ACIU)? Insider Monkey
Nov-05-19 10:33AM	AC Immune (ACIU) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-24-19 07:00AM	AC Immune to Host Key Opinion Leader Event: Untangling Tau Pathology to Treat Alzheimers and Neurodegenerative Diseases GlobeNewswire
Sep-25-19 08:52AM	These Factors Make AC Immune SA (NASDAQ:ACIU) An Interesting Investment Simply Wall St.
Sep-23-19 01:22PM	AC Immune to Earn Milestone From Lilly for Alzheimer's Drug Zacks
Sep-20-19 10:02AM	6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day Zacks
07:00AM	AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program GlobeNewswire
Sep-17-19 02:00AM	AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620 GlobeNewswire
Sep-04-19 07:00AM	AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinsons Disease Diagnostic Imaging Agent GlobeNewswire
Aug-19-19 12:31PM	Is AC Immune (NASDAQ:ACIU) Using Too Much Debt? Simply Wall St. +6.51%
Aug-14-19 07:00AM	AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update GlobeNewswire
Aug-12-19 07:00AM	AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases GlobeNewswire
Aug-07-19 10:30AM	Analysts Estimate AC Immune (ACIU) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-18-19 10:26AM	AC Immune Initiates Phase I Study for Alzheimer's Disease Zacks -6.96%
Jul-17-19 07:00AM	AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer, an Investigational Treatment for Alzheimers Disease GlobeNewswire +5.56%
Jul-11-19 08:00AM	AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimers Disease-like Symptoms in Subjects with Down Syndrome GlobeNewswire
Jul-10-19 10:52AM	Introducing AC Immune (NASDAQ:ACIU), The Stock That Slid 66% In The Last Year Simply Wall St.
Jun-29-19 06:07PM	Heres What Hedge Funds Think About AC Immune SA (ACIU) Insider Monkey
Jun-28-19 08:36AM	AC Immune Announces Election of New Chairman of the Board at Annual General Meeting GlobeNewswire
Jun-27-19 07:00AM	AC Immune to Host Key Opinion Leader Meeting on Treating Alzheimers in Down Syndrome GlobeNewswire
Jun-20-19 07:00AM	AC Immune Reports Initiation of a Phase 2 Substudy to Increase Understanding of Disease Progression in Familial Alzheimers Disease GlobeNewswire
May-15-19 08:35AM	AC Immune (ACIU) Lags Q1 Earnings and Revenue Estimates Zacks
07:36AM	AC Immune: 1Q Earnings Snapshot Associated Press
07:00AM	AC Immune Reports Q1 2019 Financial Results and Business Update GlobeNewswire
May-08-19 01:27PM	Heres What Hedge Funds Think About AC Immune SA (ACIU) Insider Monkey
Apr-24-19 10:33AM	AC Immune (ACIU) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks
Apr-09-19 07:02AM	What Percentage Of AC Immune SA (NASDAQ:ACIU) Shares Do Insiders Own? Simply Wall St.
Apr-03-19 09:58AM	Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003 Zacks
Apr-01-19 07:00AM	AC Immune to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
Mar-29-19 02:00AM	AC Immune Presents New Data on Alpha-Synuclein PET Tracer at AD/PD Conference GlobeNewswire
Mar-27-19 10:48AM	Lilly (LLY) Signs New Immunology Deal With Private Biotech Zacks

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops therapeutic and diagnostic products for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company's lead product candidate is crenezumab, a humanized, monoclonal, and conformation-specific anti-Abeta antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is in Phase II clinical study for AD, as well as is in Phase Ib clinical study for Down syndrome; ACI-35, an anti-Tau vaccine candidate that has completed Phase Ib clinical study; RG6100, an anti-Tau antibody candidate, which is in Phase II clinical study for AD patients; and Tau-PET imaging tracer that has completed Phase I clinical study. In addition, the company is researching and developing Tau Morphomer aggregation inhibitor small molecules for AD. Further, it has discovery and pre-clinical stage molecules targeting neurodegenerative diseases, as well as diagnostics targeting Tau, alpha-synuclein, and TDP-43 aggregates. The company has license agreements and collaborations with Genentech, Inc.; Biogen International GmbH; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; Eli Lilly and Company; Essex Bio-Technology Limited; and WuXi Biologics. It also has a research collaboration with University of Pennsylvania to focus on pathogenic protein TDP-43 in neurodegenerative diseases. AC Immune SA was founded in 2003 and is headquartered in Lausanne, Switzerland.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience